Immunohistochemical and western blot findings revealed that bFGF treatment significantly inhibited 6-OHDA-induced increase in the expression of GRP78/BiP and CHOP, thus providing evidence on the regulation of GRP78/BiP as a neuroprotective mechanism in PD [98]. The gene discussed is HSPA5; the disease is Parkinson disease.